Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →GCPL reported a steady quarter with India standalone volume growth of 7% and value growth of 7%, but EBITDA was flat due to high palm oil inflation.
✓ Verified against BSE filing
GCPL reported a steady quarter with India standalone volume growth of 7% and value growth of 7%, but EBITDA was flat due to high palm oil inflation. The company maintained A&P spend at 11.6% despite margin pressure, emphasizing quality over cost-cutting. International markets showed mixed performance: Indonesia delivered 7% volume growth and 17% EBITDA growth, while GAUM saw organic volume decline of 8% but EBITDA grew 33% as margins improved to 14.5%. LatAm rebounded strongly with 50% UVG and double-digit EBITDA margins. Management highlighted green shoots from the RNF molecule relaunch in HI, particularly in coils and incense sticks, but cautioned that electrics may take another quarter. Key risks include sustained palm oil inflation, urban GT slowdown, and competitive pressure in soaps from structuring technologies. The company expects volume growth to remain range-bound near high single digits for the next couple of quarters.
GCPL ने इस तिमाही में अच्छा प्रदर्शन किया। भारत में बिक्री की मात्रा 7% और मूल्य 7% बढ़ा, लेकिन मुनाफा (EBITDA) स्थिर रहा क्योंकि पाम तेल की कीमतें बहुत बढ़ गईं। कंपनी ने विज्ञापन पर खर्च 11.6% रखा, भले ही मुनाफा कम हुआ। अंतरराष्ट्रीय बाजारों में मिला-जुला प्रदर्शन रहा: इंडोनेशिया में मात्रा 7% और मुनाफा 17% बढ़ा, जबकि GAUM में मात्रा 8% घटी लेकिन मुनाफा 33% बढ़ा। लैटिन अमेरिका में 50% बिक्री बढ़ी। कंपनी ने नए उत्पादों से उम्मीद जताई, लेकिन बिजली के उत्पादों में सुधार में समय लग सकता है। मुख्य जोखिम पाम तेल की बढ़ती कीमतें और बाजार में प्रतिस्पर्धा हैं। अगली तिमाहियों में मात्रा में 7-9% की बढ़ोतरी रह सकती है।
0 delivered, 0 close, 1 missed.
View Promises →Palm oil inflation and import duty impact
View Risks →Full transcript text is available on this route.
Read Transcript →India business grew 7% volume and 7% value, with EBITDA flat due to palm oil inflation.
Indonesia delivered 7% volume growth and 17% EBITDA growth, driven by core categories.
GAUM organic volumes declined 8% but EBITDA grew 33%, with margins improving to 14.5%.
LatAm business performed well with 50% underlying volume growth and double-digit EBITDA margins.
Management expects India standalone EBITDA margins to stay between 24% and 25% due to volatile palm oil prices, with no plans to cut media investments.
The Raymond consumer portfolio EBITDA may be slightly below the promised 145-150 crore for the year due to distribution missteps in urban general trade.
Management targets high single-digit volume growth for household insecticides, driven by RNF molecule rollout and distribution expansion.
Africa EBITDA margins are expected to reach high teens, driven by supply chain efficiencies and stable macro conditions.
Management expects pricing to become positive sequentially from Q2, with full-year pricing growth of 2-3%.
Management aims for low double-digit volume growth in India for the full year, implying acceleration from 8% in Q1.
Raymond acquisition EBITDA for FY25 is expected to be 15-20% below the original target of INR 160 crore, but significantly higher than the inherited INR 60 crore.
Godrej Pet Care is expected to become cash positive after five years, with manufacturing commencing in H2 FY26.
Sharp increase in palm oil and crude palm stearin prices due to import duties is pressuring margins, with sequential inflation of 25% on CPS.
Urban general trade is under pressure from quick commerce disruption and consumption slowdown, which could impact distribution and sales.
Raymond consumer portfolio may miss the 145-150 crore EBITDA target due to distribution issues in urban GT, though management expects only a slight shortfall.
Market leader's adoption of bathing bar technology could widen price gap, though management believes quality focus will protect market share.
Extreme currency fluctuations in Nigeria and Ghana led to distributor destocking and a 21% volume decline in GAUM. High interest rates may prolong the destocking.
Sharp increase in palm oil prices pressured India EBITDA margins in Q1, and management noted it as a headwind for the year.
Integration of urban general trade distribution led to market share loss in deodorants. Management is reverting to a specialized channel, which may delay profit targets.
The INR 500 crore investment in pet care is a long-term bet with uncertain returns. Management acknowledged EBITDA margins may be lower than HPC.
Mentioned in Q2 FY24, Q3 FY24
Management anticipates steady improvement in EBITDA margins through structural cost reduction actions.
Management expects India standalone EBITDA margins to stay between 24% and 25% due to volatile palm oil prices, with no plans to cut media investme...
Sharp increase in palm oil and crude palm stearin prices due to import duties is pressuring margins, with sequential inflation of 25% on CPS.
View Risks →